ClinConnect ClinConnect Logo
Search / Trial NCT06686277

Effects Of Gong's Versus Mulligan Mobilization In Patients With Adhesive Capsulitis

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Nov 12, 2024

Trial Information

Current as of August 24, 2025

Recruiting

Keywords

Adhesive Capsulitis Functional Disability Range Of Motion

ClinConnect Summary

This clinical trial is exploring two different treatment techniques for patients who have a condition called adhesive capsulitis, commonly known as frozen shoulder. In this condition, the shoulder becomes stiff and painful, making it hard to move. The trial will compare the effects of two types of physical therapy, Gong's mobilization and Mulligan mobilization, to see which one helps patients feel better and regain their shoulder movement more effectively.

To participate in this study, you should be between 40 and 50 years old, and have already been diagnosed with a frozen shoulder that is in the "frozen phase." If you have had recent shoulder surgery, fractures, or certain other conditions, you may not be eligible. If you qualify and decide to join, you will be randomly placed into one of the two treatment groups. Throughout the trial, healthcare professionals will monitor your progress and evaluate how the treatments affect your shoulder. This study aims to help improve treatment options for individuals suffering from this painful condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 40 to 50 years
  • Both male and female
  • Pre-diagnosed Unilateral Primary Frozen shoulder patients
  • Prediagnosed Stage 3(Frozen phase) patients(27)
  • Exclusion Criteria:
  • Patients with previous surgery in the shoulder joint
  • History of recent fracture or severe trauma to the shoulder
  • Diagnosed instability or previous history of dislocation
  • Systemic inflammatory conditions(e.g.rheumatoid arthritis)

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Lahore, Punjab, Pakistan

Patients applied

0 patients applied

Trial Officials

Muhammad Hassan, MSPT

Principal Investigator

Riphah International University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported